{"bill":{"bill_id":1689282,"change_hash":"05102c15b742620f35f4dffb5f65b277","session_id":2002,"session":{"session_id":2002,"state_id":42,"year_start":2023,"year_end":2024,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023-2024 Regular Session","session_name":"113th General Assembly"},"url":"https:\/\/legiscan.com\/TN\/bill\/SB1314\/2023","state_link":"https:\/\/wapp.capitol.tn.gov\/apps\/Billinfo\/default.aspx?BillNumber=SB1314&ga=113","completed":0,"status":1,"status_date":"2023-01-31","progress":[{"date":"2023-01-31","event":1}],"state":"TN","state_id":42,"bill_number":"SB1314","bill_type":"B","bill_type_id":"1","body":"S","body_id":90,"current_body":"S","current_body_id":90,"title":"AN ACT to amend Tennessee Code Annotated, Title 53; Title 56; Title 63; Title 68 and Title 71, relative to medications intended for persons with diabetes.","description":"As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription medication for diabetes as a prescription drug that has a listed indication for diabetes and may also be used for purposes of weight loss in persons who do not have a diagnosis of diabetes. - Amends TCA Title 53; Title 56; Title 63; Title 68 and Title 71.","pending_committee_id":2855,"committee":{"committee_id":2855,"chamber":"S","chamber_id":90,"name":"Commerce and Labor"},"referrals":[{"date":"2023-02-06","committee_id":2855,"chamber":"S","chamber_id":90,"name":"Commerce and Labor"}],"history":[{"date":"2023-01-31","action":"Filed for introduction","chamber":"S","chamber_id":90,"importance":1},{"date":"2023-02-02","action":"Introduced, Passed on First Consideration","chamber":"S","chamber_id":90,"importance":0},{"date":"2023-02-06","action":"Passed on Second Consideration, refer to Senate Commerce and Labor Committee","chamber":"S","chamber_id":90,"importance":0}],"sponsors":[{"people_id":16127,"person_hash":"15mlpl74","party_id":"2","state_id":42,"party":"R","role_id":2,"role":"Sen","name":"Paul Bailey","first_name":"Paul","middle_name":"E.","last_name":"Bailey","suffix":"","nickname":"","district":"SD-015","ftm_eid":6607075,"votesmart_id":49079,"opensecrets_id":"","knowwho_pid":483071,"ballotpedia":"Paul_Bailey_(Tennessee)","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[{"type_id":5,"type":"Crossfiled","sast_bill_number":"HB1419","sast_bill_id":1688425}],"subjects":[{"subject_id":15216,"subject_name":"Drugs, Prescription"}],"texts":[{"doc_id":2673870,"date":"2023-01-31","type":"Draft","type_id":9,"mime":"application\/pdf","mime_id":2,"url":"https:\/\/legiscan.com\/TN\/text\/SB1314\/id\/2673870","state_link":"https:\/\/www.capitol.tn.gov\/Bills\/113\/Bill\/SB1314.pdf","text_size":8655,"text_hash":"6a152d7ff2a156c3bd701f8a46aa2caa"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}